BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32921126)

  • 1. Relationship of serum ATPase activity and the levels of neuron- specific enolase, S100B and B-cell lymphoma/leukemia-2 with cognitive function after epileptic seizure.
    Zhang Y; Zhang S; Ji Y; Yang X; Liu P; Yu G
    Ann Palliat Med; 2020 Sep; 9(5):3366-3372. PubMed ID: 32921126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.
    Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A
    Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with chronic insomnia disorder have increased serum levels of neurofilaments, neuron-specific enolase and S100B: does organic brain damage exist?
    Zhang P; Tan CW; Chen GH; Ge YJ; Xu J; Xia L; Wang F; Li XY; Kong XY
    Sleep Med; 2018 Aug; 48():163-171. PubMed ID: 29957487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus.
    Hanin A; Denis JA; Frazzini V; Cousyn L; Imbert-Bismut F; Rucheton B; Bonnefont-Rousselot D; Marois C; Lambrecq V; Demeret S; Navarro V
    J Neurol; 2022 Jul; 269(7):3752-3760. PubMed ID: 35190890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Blood-Based Brain Biomarker Levels in Patients with Epileptic Seizures: A Systematic Review and Meta-analysis.
    Simani L; Sadeghi M; Ryan F; Dehghani M; Niknazar S
    ACS Chem Neurosci; 2020 Dec; 11(24):4048-4059. PubMed ID: 33147022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of Serum Neuron-Specific Enolase Combined with Serum S100B Protein in the Diagnosis of Systemic Lupus Erythematosus.
    Chen J; Yan Cheng ; Zhang X; Wang F; Chuai X
    Contrast Media Mol Imaging; 2022; 2022():9390991. PubMed ID: 35615727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value.
    Gao Y; Duan J; Ji H; Lu W
    Ann Palliat Med; 2021 Mar; 10(3):3371-3378. PubMed ID: 33849122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and study of S100 calcium-binding protein B and Neuron-specific enolase-based predictive model for epilepsy secondary to cerebral infarction.
    Fang Wen ; Lizhi Yu ; Chengcai Xia ; Zhenghua Gu
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):130-135. PubMed ID: 37114260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus.
    Hanin A; Demeret S; Denis JA; Nguyen-Michel VH; Rohaut B; Marois C; Imbert-Bismut F; Bonnefont-Rousselot D; Levy P; Navarro V; Lambrecq V
    Eur J Neurol; 2022 Mar; 29(3):883-889. PubMed ID: 34687105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the postoperative cognitive dysfunction in elderly patients with general anesthesia.
    Chi YL; Li ZS; Lin CS; Wang Q; Zhou YK
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1346-1354. PubMed ID: 28387891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B protein and neuron-specific enolase as predictors of postoperative cognitive dysfunction in aged dogs: a case-control study.
    Zbóril S; Schmidt AP; Oses JP; Wiener CD; Portela LV; Souza DO; Auler JOC; Carmona MJC; Fugita MS; Flor PB; Cortopassi SRG
    Vet Anaesth Analg; 2020 Nov; 47(6):740-747. PubMed ID: 32800537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a strategy for assessing blood-brain barrier disruption using serum S100 calcium-binding protein B and neuron-specific enolase in early stage of neuroemergencies: A preliminary study.
    Yun GS; In YN; Kang C; Park JS; You Y; Min JH; Ahn HJ; Yoo I; Kim SW; Oh SK; Lee IH; Kim DM
    Medicine (Baltimore); 2022 Jul; 101(28):e29644. PubMed ID: 35839066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
    Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
    Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury.
    Du W; Li H; Sun J; Xia Y; Zhu R; Zhang X; Tian R
    Med Sci Monit; 2018 Jun; 24():4510-4515. PubMed ID: 29959890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum S100B represents a biomarker for cognitive impairment in patients with end-stage renal disease.
    Park BS; Lee HW; Lee YJ; Park S; Kim YW; Kim SE; Kim IH; Park JH; Park KM
    Clin Neurol Neurosurg; 2020 Aug; 195():105902. PubMed ID: 32442806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study.
    Silva FP; Schmidt AP; Valentin LS; Pinto KO; Zeferino SP; Oses JP; Wiener CD; Otsuki DA; Tort AB; Portela LV; Souza DO; Auler JO; Carmona MJ
    Eur J Anaesthesiol; 2016 Sep; 33(9):681-9. PubMed ID: 27433840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?
    Yilmaz N; Karaali K; Ozdem S; Turkay M; Unal A; Dora B
    Cell Mol Neurobiol; 2011 May; 31(4):579-85. PubMed ID: 21293918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.
    Li Y; Yu ZX; Ji MS; Yan J; Cai Y; Liu J; Yang HF; Jin ZC
    J Intensive Care Med; 2019 Aug; 34(8):674-681. PubMed ID: 28569132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy.
    Asadova V; Gul Z; Buyukuysal RL; Yalcinbayir O
    Int Ophthalmol; 2020 Jan; 40(1):227-234. PubMed ID: 31571092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.